7115-91-5

Basic information

• Product Name: ETHYL 2-(BROMOMETHYL)BENZOATE
• Synonyms: Ethyl2-(bromomethyl)benzoate97%;Ethyl 2-(bromomethyl);ETHYL 2-(BROMOMETHYL)BENZOATE;EthylO-(Bromomethyl)Benzoate;2-(Ethoxycarbonyl)benzyl bromide;2-(Ethoxycarbonyl)benzyl bromide, Ethyl alpha-bromo-o-toluate
• CAS NO: 7115-91-5
• Molecular Formula: C₁₀H₁₁BrO₂
• Molecular Weight: 243.1
• Product Categories: Methyl Halides;Phenyls & Phenyl-Het;Methyl Halides;Phenyls & Phenyl-Het
• Mol File: 7115-91-5.mol
• Article Data: 44

Chemical Properties

• Boiling Point: 308.572°C at 760 mmHg
• Flash Point: 140.42°C
• Appearance: /
• Density: 1.403g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.551
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: ETHYL 2-(BROMOMETHYL)BENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 2-(BROMOMETHYL)BENZOATE(7115-91-5)
• EPA Substance Registry System: ETHYL 2-(BROMOMETHYL)BENZOATE(7115-91-5)

Safety Data

• Hazardous Substances Data: 7115-91-5(Hazardous Substances Data)

Usage

General Description

ETHYL 2-(BROMOMETHYL)BENZOATE is a chemical compound that is commonly used in the synthesis and production of various organic compounds. It is an ester of benzoic acid and ethyl alcohol with a bromomethyl functional group attached to the benzene ring. ETHYL 2-(BROMOMETHYL)BENZOATE is often utilized in organic chemistry as a building block for the synthesis of biologically active molecules, pharmaceuticals, and agrochemicals. It is known for its versatile reactivity and ability to participate in a wide range of organic reactions, making it a valuable component in the manufacturing of various products across different industries. Additionally, it is important to handle this compound with proper safety precautions, as it is a potentially hazardous substance.

InChI:InChI=1/C10H11BrO2/c1-2-13-10(12)9-6-4-3-5-8(9)7-11/h3-6H,2,7H2,1H3

Upstream product

• 64-17-5 ethanol 
• 7115-90-4 α-Bromo-o-toluyl Chloride 
• 87-24-1 ethyl 2-methylbenzoate 
• 118-90-1 ortho-methylbenzoic acid 
• 20924-53-2 ethyl <(2-carbethoxybenzyl)oxy>acetate 
• 7115-89-1 2-(bromomethyl)benzoic acid 
• 75-16-1 methylmagnesium bromide 
• 487-97-8 1-ethoxy-1,3-dihydroisobenzofuran-1-ylium borofluorate 
• 934-01-0 2-bromobenzocyclobutenone 
• 40819-28-1 2-(bromomethyl)benzoyl bromide 

Downstream Products

• 861363-10-2 3-(2-ethoxycarbonyl-phenyl)-2-cyano-propionic acid ethyl ester 
• 88550-19-0 benzoic acid 2-methoxy-methyl ester 
• 96259-60-8 ethyl 2-(ethoxymethyl)benzoate 
• 409109-51-9 2-phthalimidomethyl-benzoic acid ethyl ester 
• 118-90-1 ortho-methylbenzoic acid 
• 87-41-2 2-benzofuran-1(3H)-one 
• 37558-41-1 2-Benzyl-2-(2-ethoxycarbonyl-benzyl)-malonic acid diethyl ester 
• 14961-34-3 diethyl homophthalate 
• 79026-11-2 diethyl (2-ethoxycarbonyl)-benzyl phosphonate 
• 19821-21-7 (2-carbethoxyphenyl)acetonitrile 
• 70555-95-2 3-(3,4-dimethoxyphenyl)-3,4-dihydro-1H-isochromen-1-one 
• 2674-44-4 3-phenyl-isochroman-1-one 
• 95217-41-7 3-(4-methylphenyl)-3,4-dihydro-1H-isochromen-1-one 
• 37568-81-3 3,4-dihydro-3-(4-methoxyphenyl)-1H-2-benzopyran-1-one 

Relevant articles and documents

Metal Complexes with Macrocyclic Ligands Part XXV One-Step Synthesis of Mono-N-substituted Azamacrocycles with a Carboxylic Group in the Side-Chain and their Complexes with Cu2+ and Ni2+

Mono-N-substituted azamacrocycles 2-7, containing a carboxyalkyl or carboxyaryl side-chain, are obtained by reacting a five-fold excess of the macrocycle with 1 equiv. of a suitable halogenocarboxylic acid in alkaline aqueous EtOH.For halogenocarboxylic a

Development of LM98, a Small-Molecule TEAD Inhibitor Derived from Flufenamic Acid

The YAP-TEAD transcriptional complex is responsible for the expression of genes that regulate cancer cell growth and proliferation. Dysregulation of the Hippo pathway due to overexpression of TEAD has been reported in a wide range of cancers. Inhibition of TEAD represses the expression of associated genes, demonstrating the value of this transcription factor for the development of novel anti-cancer therapies. We report herein the design, synthesis and biological evaluation of LM98, a flufenamic acid analogue. LM98 shows strong affinity to TEAD, inhibits its autopalmitoylation and reduces the YAP-TEAD transcriptional activity. Binding of LM98 to TEAD was supported by 19F-NMR studies while co-crystallization experiments confirmed that LM98 is anchored within the palmitic acid pocket of TEAD. LM98 reduces the expression of CTGF and Cyr61, inhibits MDA-MB-231 breast cancer cell migration and arrests cell cycling in the S phase during cell division.

INFLUENZA VIRUS REPLICATION INHIBITOR AND USES THEREOF

The invention belongs to the field of medicine, and particularly relates to a novel compound as a replication inhibitor of influenza virus and a preparation method thereof, a pharmaceutical composition comprising the compound and use of the compound and pharmaceutical composition thereof in treating influenza. The present invention provides a compound having Formula (I) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, The compound of the present invention can inhibit influenza virus well, and/or has lower cytotoxicity, better in vivo pharmacokinetic properties and in vivo pharmacodynamic properties.